Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haopeng Sun

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Bioorganic Chemistry|October 7, 2019
Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitorsJun Mo, Hongyu Yang, Tingkai Chen, et al.
Cell Communication and Signaling : CCS|April 17, 2026
STAT1 itaconation prevents macrophage cytolistic mtDNA -induced inflammation in wear particle-induced aseptic looseningYifan Yu, Taihe Liu, Chenhao Pan, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug ResistanceSiyu He, Yang Liu, Xianglin Chu, et al.
ACS Chemical Neuroscience|March 7, 2024
Discovery, Structure-Based Modification, <i>In Vitro</i>, <i>In Vivo</i>, and <i>In Silico</i> Exploration of <i>m</i>-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's DiseaseXin Lu, Yueqing Li, Qianwen Guan, et al.
Bioorganic Chemistry|January 28, 2020
Design, synthesis and evaluation of wound healing activity for β-sitosterols derivatives as potent Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitorsShaoyu Cui, Hongli Jiang, Lei Chen, et al.
European Journal of Medicinal Chemistry|September 20, 2020
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's diseaseXueyang Jiang, Junting Zhou, Yang Wang, et al.
European Journal of Medicinal Chemistry|March 7, 2024
Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular planeShuaishuai Xing, Xu Tang, Leyan Wang, et al.
Bioorganic & Medicinal Chemistry|February 25, 2018
Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's diseaseXin Lu, Si-Yu He, Qi Li, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 8, 2015
Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated UbiquitinationJinlian Wei, Yingrui Yang, Mengchen Lu, et al.
Journal of Medicinal Chemistry|February 21, 2022
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial DiseasesTingkai Chen, Tianyu Sun, Yaoyao Bian, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Bioorganic Chemistry|October 7, 2019
Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitorsJun Mo, Hongyu Yang, Tingkai Chen, et al.
Cell Communication and Signaling : CCS|April 17, 2026
STAT1 itaconation prevents macrophage cytolistic mtDNA -induced inflammation in wear particle-induced aseptic looseningYifan Yu, Taihe Liu, Chenhao Pan, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug ResistanceSiyu He, Yang Liu, Xianglin Chu, et al.
ACS Chemical Neuroscience|March 7, 2024
Discovery, Structure-Based Modification, <i>In Vitro</i>, <i>In Vivo</i>, and <i>In Silico</i> Exploration of <i>m</i>-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer's DiseaseXin Lu, Yueqing Li, Qianwen Guan, et al.
Bioorganic Chemistry|January 28, 2020
Design, synthesis and evaluation of wound healing activity for β-sitosterols derivatives as potent Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitorsShaoyu Cui, Hongli Jiang, Lei Chen, et al.
European Journal of Medicinal Chemistry|September 20, 2020
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's diseaseXueyang Jiang, Junting Zhou, Yang Wang, et al.
European Journal of Medicinal Chemistry|March 7, 2024
Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular planeShuaishuai Xing, Xu Tang, Leyan Wang, et al.
Bioorganic & Medicinal Chemistry|February 25, 2018
Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer's diseaseXin Lu, Si-Yu He, Qi Li, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 8, 2015
Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated UbiquitinationJinlian Wei, Yingrui Yang, Mengchen Lu, et al.
Journal of Medicinal Chemistry|February 21, 2022
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial DiseasesTingkai Chen, Tianyu Sun, Yaoyao Bian, et al.
Pageof 17